OCEANSIDE, Calif., Aug. 8, 2018 /PRNewswire/ -- AOTI Inc. announced today the opening of an expanded manufacturing facility in Galway, Ireland for the production of its patented Topical Wound Oxygen ...

Patients suffering from chronic diabetic foot ulcers (DFUs) could experience at least a fourfold increase in healing over standard of care with 12 weeks of home-based topical wound oxygen (TWO2) ...

OCEANSIDE, Calif., June 11, 2019 /PRNewswire/ -- AOTI Inc. announced today that over the last month it had successfully participated in three of the world's leading wound care conferences; the ...

(Sharecast News) - Aoti said on Wednesday that its 'Topical Wound Oxygen', or 'TWO2', therapy has gained a fast-track treatment recommendation from the National Institute for Health and Care ...

(MENAFN- PR Newswire) NEXA NPWT System Launched in the USA OCEANSIDE, Calif., June 7, 2023 /PRNewswire/ -- AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news ...

TWO 2 ® therapy is now active on NHS Supply Chains’ Advanced Wound Care Framework Enables accelerated marketing in the UK AOTI, INC. (AIM: AOTI), a medical technology group focused on the durable ...

Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration ...

Peer-reviewed health economic study shows TWO2® therapy would significantly lower overall diabetic foot care costs for NHS in England AOTI, INC. (AIM: AOTI), a medical technology group focused on the ...

OCEANSIDE, Calif. - AOTI, Inc. (AIM:AOTI) announced Monday it has been granted a provider ID in California’s Medicaid program, allowing the company to seek insurance coverage for its TWO2® therapy in ...